First Personalized Gene Therapy Using Base Editing Shows Promising Results in Baby with Rare Disorder
- In February 2025, a six-month-old infant named KJ Muldoon from Pennsylvania received the first personalized CRISPR gene editing therapy for severe CPS1 deficiency.
- The therapy aimed to correct KJ's faulty gene that causes a deficiency of an enzyme leading to toxic ammonia build-up and high infant mortality.
- Within half a year, a medical team from Philadelphia-based institutions developed a tailored gene therapy and administered the initial treatment in February 2025, followed by additional doses in March and April.
- KJ has improved protein intake, reduced medication, and recovered from illnesses without ammonia spikes, while researchers stress longer monitoring is needed.
- This milestone suggests personalized base-editing might expand rare disease treatments, though substantial barriers and high costs remain before wider availability occurs.
236 Articles
236 Articles
Washington Should Fund More Potential Science Miracles
A baby boy, born in Philadelphia in 2024 with a potentially fatal genetic deficiency, has become the first person treated with a custom gene-editing therapy. Doctors used CRISPR technology to rapidly create a personalized treatment for KJ, targeting the child’s specific mutation. The boy is meeting developmental milestones, his weight is in the 40th percentile, but his need for a liver transplant is still unknown, according to news reports. This…
From birth to gene-edited in 6 months: Custom therapy breaks speed limits
News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, with a personalized CRISPR gene-editing therapy. The treatment corrects an ultra-rare mutation in KJ that breaks a liver enzyme. That enzyme is required to convert ammonia, a byproduct of metabolism, to urea, a waste product released in urine. Without treatment, ammonia would build up to dangerous levels in KJ—and he would…
World's first successful tailor-made gene therapy saves baby born with rare disorder
Baby KJ Muldoon was born with a rare genetic condition that is often fatal, but doctors used custom CRISPR gene therapy to target the exact mutation in his DNA. His family shares their emotional journey in their first TV interview with CBS News.
Coverage Details
Bias Distribution
- 59% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage